DSPE-PEG-PTX（磷脂-聚乙二醇-紫杉醇）是一种由磷脂、聚乙二醇和抗肿瘤药物紫杉醇（一种广谱抗肿瘤药物，通过稳定微管抑制细胞分裂，主要用于 ...

Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer. J. Clin. Oncol. 26, 5544–5552 (2008).

The FDA granted an orphan drug designation to PEP-010 for the treatment of patients with metastatic pancreatic cancer.

Telomir Pharmaceuticals (TELO) announced preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a ...

Telomir Pharmaceuticals (NASDAQ:TELO) announced on Wednesday, preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model using highly ...

The Medtronic Prevail drug coated balloon [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced results from a ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Adding afuresertib to paclitaxel did not improve outcomes in patients with platinum-resistant ovarian cancer in a phase 2 trial.

Medtronic plc reported results from a registry highlighting the effectiveness of the Prevail paclitaxel-coated balloon. The findings from the Swedish Coronary Angiography and Angioplasty Registry ...